| Stable gastric pentadecapeptide BPC 157-NO-system relation P Sikiric, S Seiwerth, R Rucman, B Turkovic, D Stancic Rokotov, L Brcic, ... Current pharmaceutical design 20 (7), 1126-1135, 2014 | 144 | 2014 |
| Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse M Lovric-Bencic, P Sikiric, JS Hanzevacki, S Seiwerth, D Rogic, V Kusec, ... Journal of pharmacological sciences 95 (1), 19-26, 2004 | 143 | 2004 |
| Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157 P Sikiric, S Seiwerth, R Rucman, B Turkovic, D Stancic Rokotov, L Brcic, ... Current pharmaceutical design 19 (1), 76-83, 2013 | 135 | 2013 |
| Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice D Mikus, P Sikiric, S Seiwerth, A Petricevic, G Aralica, N Druzijancic, ... Burns 27 (8), 817-827, 2001 | 131 | 2001 |
| Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth M Staresinic, B Sebecic, L Patrlj, S Jadrijevic, S Suknaic, D Perovic, ... Journal of orthopaedic research 21 (6), 976-983, 2003 | 122 | 2003 |
| BPC 157 and blood vessels S Seiwerth, L Brcic, L Batelja Vuletic, D Kolenc, G Aralica, M Misic, ... Current pharmaceutical design 20 (7), 1121-1125, 2014 | 97 | 2014 |
| A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine P Sikiric, A Marovic, W Matoz, T Anic, G Buljat, D Mikus, ... Journal of Physiology-Paris 93 (6), 505-512, 1999 | 91 | 1999 |
| The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation P Sikiric, J Šeparovic, T Anic, G Buljat, D Mikus, S Seiwerth, Z Grabarevic, ... Journal of Physiology-Paris 93 (6), 479-485, 1999 | 87 | 1999 |
| Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability R Kliček, D Kolenc, J Šuran, D Drmić, L Brčić, G Aralica, M Sever, ... Journal of physiology and pharmacology 64 (5), 597-612, 2013 | 85 | 2013 |
| New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin P Sikirić, S Seiwerth, S Dešković, Z Grabarević, A Marović, R Ručman, ... European journal of pharmacology 364 (1), 23-31, 1999 | 75 | 1999 |
| Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. I Prkacin, G Aralica, D Perovic, J Separovic, M Gjurasin, M Lovric-Bencic, ... Journal of Physiology-Paris 95 (1-6), 295-301, 2001 | 66 | 2001 |
| Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and … P Sikiric, S Seiwerth, Z Grabarevic, I Balen, G Aralica, M Gjurasin, ... Journal of Physiology-Paris 95 (1-6), 261-270, 2001 | 57 | 2001 |
| Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157 P Sikiric, J Šeparovic, G Buljat, T Anic, D Stancic-Rokotov, D Mikus, ... Journal of Physiology-Paris 94 (2), 105-110, 2000 | 57 | 2000 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and … I Bilic, I Zoricic, T Anic, J Separovic, D Stancic-Rokotov, D Mikus, G Buljat, ... Life sciences 68 (16), 1905-1912, 2001 | 54 | 2001 |
| Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat P Sikiric, S Seiwerth, G Aralica, D Perovic, M Staresinic, T Anic, ... Journal of Physiology-Paris 95 (1-6), 283-288, 2001 | 53 | 2001 |
| Mortal furosemide-hypokalemia-disturbances in rats NO-system related. Shorten survival by L-NAME. Therapy benefit with BPC 157 more than with L-arginine. I Balenovic, I Barisic, I Prkacin, M Horvat, S Udovicic, D Uzun, D Strinic, ... Journal of clinical & experimental cardiology 10 (X), 1-10, 2012 | 51 | 2012 |
| Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats P Sikiric, S Jadrijevic, S Seiwerth, T Sosa, S Deskovic, D Perovic, ... Journal of Physiology-Paris 93 (6), 467-477, 1999 | 49 | 1999 |
| Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. P Sikiric, N Jelovac, A Jelovac-Gjeldum, G Dodig, M Staresinic, T Anic, ... Acta Pharmacologica Sinica 23 (5), 412-422, 2002 | 45 | 2002 |
| Duodenocutaneous fistula in rats as a model for “wound healing-therapy” in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine S Skorjanec, A Kokot, D Drmic, B Radic, M Sever, R Klicek, D Kolenc, ... J Physiol Pharmacol 66 (4), 581-90, 2015 | 44 | 2015 |
| The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants P Sikiric, J Šeparovic, G Buljat, T Anic, D Stancic-Rokotov, D Mikus, ... Journal of Physiology-Paris 94 (2), 99-104, 2000 | 42 | 2000 |
